Phaseline

Targets › TYMB

TYMB: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease.

Open in Phaseline: the race on TYMB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Air Force Specialized Hospital, Cairo, EgyptTigecycline
Bacterial 70S ribosome inhibitor
TYMBPhase 4Multi Drug Resistant Infections–

Conditions

Multi Drug Resistant Infections (1)

Modalities

small molecule (1)

Companies

Air Force Specialized Hospital, Cairo, Egypt (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.